CyanVac, a Georgia-based pharmaceutical company, is
developing a COVID-19 vaccine that is delivered nasally and
uses a live virus to create immunity.
h/t dr0id
Views:
A fine selection of independent media sources
CyanVac, a Georgia-based pharmaceutical company, is
developing a COVID-19 vaccine that is delivered nasally and
uses a live virus to create immunity.
h/t dr0id